Robert Clark

Title: Innovations of Robert Clark in HIV Research

Introduction

Robert Clark is an accomplished inventor based in Woodstown, NJ (US). He has made significant contributions to the field of medical research, particularly in the area of human immunodeficiency virus (HIV) studies. With a total of 2 patents to his name, Clark's work has the potential to impact vaccine development and therapeutic strategies.

Latest Patents

Clark's latest patents focus on human lymphoid cells expressing the HIV envelope. The first patent presents mammalian cells that are modified to stably express the entire HIV-1 envelope protein gp160. This invention not only provides a vaccine comprising these modified cells but also outlines methods for screening compounds that can inhibit the formation of syncytia between cells expressing HIV-1 gp160 and CD4. The process involves mixing the modified cells with CD4-expressing cells and a test compound, followed by an assessment of syncytia formation.

Career Highlights

Robert Clark has been associated with SmithKline Beecham Corporation, where he has contributed to groundbreaking research in the field of virology. His work has been instrumental in advancing our understanding of HIV and developing potential vaccines.

Collaborations

Clark has collaborated with notable coworkers, including Zdenka Ludmila Jonak and Christine Marie Debouck. Their combined expertise has fostered an environment of innovation and discovery in their research endeavors.

Conclusion

Robert Clark's contributions to HIV research through his patents and collaborations highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in vaccine development and therapeutic approaches.